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Antibiotics Resistance: Carbapenemase-producing germs in livestock popula-
tions 
 
Information No 002/2014 from the BfR from 14 January 2014 
 
Carbapenems are antibiotics authorised for the treatment of humans and which were catego-
rised by the World Health Organization as critically important antimicrobials for the treatment 
of humans. Reserve antibiotics of this kind are only supposed to be used when standard an-
tibiotics no longer show any effects, i.e. for only stricted indications. 
 
A mechanism that leads to a resistance of bacteria to carbapenems is the formation of cer-
tain enzymes called carbapenemases. What then happens is that the active substance class 
of carbapenems can no longer be used for the treatment of infections which were caused by 
carbapenemase-producing bacteria.  
 
For the first time, the Federal Institute for Risk Assessment (BfR) has detected carbapene-
mase-producing enterobacteria in samples taken from livestock populations. As bacteria can 
transfer this carbapenem resistance to other bacterial species, consumers could theoretically 
pick up bacteria with these resistance properties via foods of animal origin or through direct 
contact with animals. Should treatment with antibiotics then be necessary, germs of this kind 
could pose a problem if the drug has no effect against the infection. The introduction of bac-
teria of this kind into hospitals could also have serious consequences and for this reason, the 
spread of carbapenemase-producing bacteria must be prevented wherever possible.  
 
The full version of this BfR Information is available in German on 
http://www.bfr.bund.de/cm/343/antibiotikaresistenz-carbapenemasebildende-keime-in-
nutztierbestaenden.pdf 
 
